Appendix 3Y
Change of Director's Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 | Amended 01/01/11 |
Name of entity | MGC Pharmaceuticals Limited |
ABN | 30 116 800 269 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Roby Reuven Zomer |
Date of last notice | 11 February 2019 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Indirect |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | 1. Chitta Lu Limited (Director and sole shareholder) 2. HSBC Custody Nominees (Australia) Limited (Beneficiary) |
Date of change | 21 February 2019 |
No. of securities held prior to change | 1. Chitta Lu Limited 10,000,000 Performance Shares 500,000 Fully Paid Ordinary Shares 2. HSBC Custody Nominees (Australia) Limited 30,000,000 Fully Paid Ordinary Shares |
Class | Fully Paid Ordinary Shares and Performance Shares |
Number acquired | 1. 1 Fully Paid Ordinary Share |
Number disposed | 1. 10,000,000 Performance Shares |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Nil - Fully Paid Ordinary Share issued on expiry and conversion of Performance Shares |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
No. of securities held after change | 1. Chitta Lu Limited 500,001 Fully Paid Ordinary Shares 2. HSBC Custody Nominees (Australia) Limited 30,000,000 Fully Paid Ordinary Shares |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Ordinary Share issued on expiry and conversion of Performance Shares. |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | |
Name of registered holder (if issued securities) | |
Date of change | |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
Interest acquired | |
Interest disposed | |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
Interest after change |
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | N/A |
If so, was prior written clearance provided to allow the trade to proceed during this period? | |
If prior written clearance was provided, on what date was this provided? |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Attachments
- Original document
- Permalink
Disclaimer
MGC Pharmaceuticals Ltd. published this content on 25 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 February 2019 03:46:01 UTC